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COMPARISONs between death rates from cancer ofparticular organs in countries
such as Denmark, Holland, Britain, Canada and the United States of America
have revealed such a measure of agreement in many instances that pronounced
differences, when they do appear between countries having good diagnostic and
registration services, are worthy of attention. If such differences cannot be
explained by variations in terminology, classification, completeness of ascertain-
ment, accuracy of death certification or facilities for treatment, a search for the
underlying reasons for them maylead inthe end to discovery ofcauses ofthe forms
ofcancer concerned. Forthatreasonitisworthwhileto calltheattentionofresearch
workers to pronounced international differences in rates which appear to satisfy
the above conditions, even though no explanation can yet be suggested.
For a long time it had been noticed that Japan's death rate from breast cancer
appeared to be very small in comparison with the rates inwesterncountries, butit
was not until about 1950 that serious attention began to be paid to this. In that
year the deaths offemales from all forms of cancer registered in Japan numbered
31,758, of which 1,419 or 4½ per cent, were assigned to breast cancer. The corre-
sponding proportion in England and Wales was 19 per cent. In a report to the
World Health Organisation Training Course on Vital and Health Statistics for
South West Pacific Areas in 1952, Professor Mitsuo Segi, by using the population
of Japan by age groups in that year as standard, calculated age-adjusted death
rates in 1949 from breast cancer in females in 8 countries to be as follows:
Canada 19.3; New Zealand 19-0; England and Wales 18.7; U.S.A. and
Netherlands 18-5; Denmark 17.9; Australia 17-2; Japan 3-3. Thiswas commented
upon in several papers read to the 5th meeting of the International Society of
Geographical Pathology atWashington D.C. in 1954 (Transactions, 1955), and no
reason has been suggested why understatement of breast cancer as underlying
cause of death should be appreciably greater in Japan than in the other countries.
Thus, Maisin and Langerock, from their analysis of the documentation on Racial
Factors (1955), concluded that "in certain countries, as e.g. Japan, where we
have every reason to believe that the documents at our disposal are especially
well proved and studied, we are certain that cancer of the breast is particularly
low . . . ". Statistics of cause of death in recent years in Japan in respect of
persons dying in early and middle life must be regarded as comparable in their
reliability with those of countries such as Britain, Norway, Holland and Canada,
although this is probably not true of rates at ages after 70.
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Justification for this qualification relating to advanced ages is to be found in
the series ofdeath rates from all forms ofcancer combined in Table 46 ofthe World
Health Organisation's report on Annual Epidemiological and Vital Statistics
(1955), where rates for year 1952 at 5-year age groups are given for 21 countries.
Perhaps the most satisfactory measure of comparison between different countries
for cancer is the Equivalent Average Death Rate at ages 35-64, that is to say the
arithmetic mean ofthe 6 rates at 5-year age groups between 35 and 65. According
to this measure Japan ranks 9th for males and 15th for females when the 21
countries are arranged in descending order of the rate, as may be seen below, the
rates being per 100,000 distributed equally over ages 35 to 64.
Males.-Finland 312; Scotland 291; Austria 275; England and Wales
269; Germany (Federal Republic) 260; Switzerland 240; France 234;
Northern Ireland 225; Japan 223; Italy 213; U.S.A. (white) 212;
Holland 209; Denmark 206; Canada 198; Australia 182; Norway 180;
New Zealand 170; Sweden 164; Israel (Jewish) 157; Portugal 139;
Ceylon 47;
Females.-Denmark 225; Scotland 221; Austria 218; Germany
(F.R.) 215; Northern Ireland 214; Holland 210; England and Wales 209;
Canada 207; U.S.A. (white) 206; Switzerland 204; New Zealand 204;
Finland 203; Sweden 199; Israel (Jewish) 196; Japan 193; Norway
184; France 176; Australia 171; Italy 171; Portugal 125; Ceylon 52.
Japan's rates for malignant neoplasms as a whole during the middle period of
life are evidently neither very high nor very low compared with countries of
Europe and North America. The male rate is higher than in Australasia, and the
female rate lies between those of Australia and New Zealand.
At ages above 70, however, Japan's ranking falls considerably; for example
at ages 70-74 it appears from the W.H.O. figures that the rates rank 18th amongst
the 21 countries for each sex. It is most unlikely that this means a real fall in
incidence at advanced ages in Japan; it suggests rather that certification of
cancer becomes incomplete amongst old people, and consequently it is best to
confine attention to death rates in middle life when making comparisons with
other countries, In Tables II and V the rates at ages over 70, though included, are
shown in italics.
Apart from records derived from death registration, morbidity rates from
breast cancer obtained in Miyagi Prefecture have been compared by Segi (1955)
with similar rates of incidence at the same ages in Denmark and Manitoba, and
these show at ages 40-49 a rate of 29 per 100,000 in contrast with 75 in Denmark
and 115 in Manitoba, at 50-59 a rate of 48 against 108 and 135, and at 60-69 a
rate of 31 against 167 and 153.
A comprehensive analysis has now been made by the Department of Public
Health at Tohoku University (Segi et al., 1955) of death rates from all forms of
cancer during the period 1900 to 1954 in Japan, and since this shows some pro-
nounced differences for a number of sites of cancer, it is advisable to set out some
of the salient facts for study and discussion. In the present paper comparison
has been made first between standardised deathrates inJapan, England andWales
and Canada in two periods, using for convenience the 1951 age distribution in
Canada as standard throughout. The Canadian rates are taken from a useful recent
report on mortality trends by the National Cancer Institute of Canada (1955).
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More detailed comparisons between age-specific rates in Japan and England
and Wales are then made,' the English rates being calculated from data in the
Registrar General's Statistical Reviews (correcting 1936-40 rates for changes in
rules for selecting the underlying cause ofdeath).
Standardised death rates in Japan, Canada, England and Wales
Table I compares the rates in Japan and Canada in 1948 with those in England
and Wales in a 5-year period centred at 1948, for the buccal cavity and pharynx,
oesophagus, stomach, intestine, rectum, larynx and lung, breast and uterus,
the numbers in parentheses being the categories in the new International Classi-
fication issued in that year. Similar rates are given for 1952 (England and Wales,
1952-54), and all these rates, standardised by applying the specific rates at 13
age groups to Canada's census population of 1951, are fully corrected for the
effects ofdiffering ageconstitution ofthepopulations. It isnotpossible to separate
cervix uteri in the Japanese statistics at present owing to the large numbers of
deaths classed to "uterus" without further definition on death certificates. The
inclusion of duodenum with stomach in the Japanese rates for 1948 has no
appreciable effect on the figures.
TABLE I.-Comparison between Standardised Death Rates*from Cancer of
certain sites in Japan, Canada and England and Wales
Males
Japan,
1948
1952 .
Canada,
1948
1952 .
England and Wales
1946-50
1952-54
Females
Japan,
1948 .
1952
Canada,
1948 .
1952
England and Wales
1946-50
1952-54
Mouth
and Oeso-
pharynx phagus Stomach
(140-8). (150). (151).
2.6 . - . 53-4t .
1-3 . 6-5 . 62-2 .
6-1
4.9 .
Intes-
tine
(152-3).
. 27-9 . 14-9 .
. 28-0 16-0 .
- . 5.2 27-5 .
4-6 . 4-6 . 26-5 .
1-5 . - 33-It·
0-6 . 2-5 . 375.
1-3 - . 161 .
1-3 . 14-0 .
- . 2-4 . 18-5 .
1-7 . 2-4 . 17-0 .
Larynx
and
Rectum lung
(154). (161-3).
Breast Uterus
(170). (171-4).
.- ~ 3.9 -9
2-1 . 3-8 . 49.
8-3 13-9 .
7.2 . 192 .
16-4 . 13-2 . 32-0 .
14-2 . 11-1 . 45'3
3.9 23-6
2-6 . 33 2-0 . 4-0 . 22-1
18-7 . 5.5 . 3-7 . 23-5 16-6
17-8 5-2 . 4-0 . 23-2 . 14-4
17-9
15-4 .
7-6 . 6-2 . 24-3 .
6-7 . 7-0 . 24-0·
13-1
11'5
* Per 100,000 living, using as standard population that of Canada in 1951.
t Including duodenum.
The Canadian rates agree closely with the English rates for the mouth and
pharynx, stomach, intestine and breast, but for rectal and respiratory cancers
they are much lower, and for uterine cancer rather higher. The Japanese rates
are about doublethose ofeither countryforstomach cancer, andforthe oesophagus
the male rate in 1952 is 1-4 times that in England and Wales. In contrast with
this, the intestinal rates in Japan are less than one:sixth of the English and
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Canadian rates, and for the rectum, mouth and pharynx they are also lower. For
the whole digestive tract Japan's rates in 1952 are 76 for males and 46 for females,
compared with 61 and 43 respectively in England and Wales, but the contribution
of intestine with rectum to these totals is only 6 for each sex in Japan compared
with about 23 in the other countries. No reason for the high gastric and low
intestinalratesinJapanisknown, butitmightwell lieinthepronounceddifferences
between the national dietaries. The low rates for respiratory cancers are seen
below to be due to the lung and bronchus, and are scarcely surprising in view of
differences in smoking and atmospheric pollution.
Breast cancer rates did not change appreciably between 1938 and 1952 in
any ofthe three countries, and the Japanese rate has remained at about one-sixth
of the Canadian and English rates. When the breast and uterus are studied in
detail of age, however, the comparison is not as simple as these figures suggest.
Mortality at different agesfrom breast, uterus, stomach and other cancer
Table II contrasts the death rates from these kinds of cancer at different ages
in Japan in 1938 and 1952 with the corresponding mean annual rates in England
TABLE II.-Comparison between Age-specific Death Rates per Millionfrom
Cancer in Japan and those in England and Wales
Breast,
Female.
Age E.
group. Jap. & W.
Uterus,
Female.
t A-~
Stomach.
Male. Female.
t t
E. E.
Jap. &W. Jap. &W.
E.
Jap. & W.
Other cancer.*
A
Male. Female.
E. E.
Jap. &W. Jap. &W.
Japan, 1938, with England and Wales, 1936-40
2
93
317
503
608
737
788
806
721
633
301
1
21
97
209
336
448
522
591
668
719
727
755
625
2
38
154
321
693
1274
2190
3224
3579
3852
2278
1
21
76
156
307
551
872
1344
1935
2503
2993
2675
1891
3
50
160
249
401
665
1173
1603
1936
2082
1322
1
18
50
86
165
278
464
770
1234
1773
2253
2267
2251
16
57
121
235
449
832
1371
1966
2334
2730
2466
Japan, 1952, with England and Wales, 1952-54
0-
25-
35-
40-
45-
50-
55-
60-
65-
70-
75-
80-
85+ }
0
11
41
74
81
116
138
132
117
140
171
182
0
32
138
296
463
565
709
836
1012
1173
1422
1789
2360
2
53
198
365
555
707
750
807
842
721
595
465
1
23
66
116
181
289
392
467
509
546
654
650
652
2
56
170
373
700
1312
2194
3288
4552
5119
4574
2869
1
14
49
117
254
449
731
1212
1774
2337
2943
3103 }
2566 f
2
54
171
288
418
666
1092
1546
2269
2666
2660
1858
1
12
33
63
121
205
343
527
883
1372
1983
2548
2595
20
43
126
231
463
828
1348
2094
2949
319I
3242
2469
52
121
280
565
1121
2259
3765
5374
7520
9690
12748
14512
16
55
120
237
342
558
857
1155
1588
1856
1888
1568
37
95
201
401
677
1103
1574
2244
3026
4035
5544
7302
* Excluding leukaemia and Hodgkin's disease. The Japanese rates in 1938 for stomach include
duodenum.
0-
25-
35-
40-
45-
50-
55-
60-
65-
70-
75-
80-
85+
0
8
22
45
67
87
98
109
111
155
191
0
28
123
263
455
622
778
927
1049
1239
1522
1834
2548
41
125
252
494
874
1596
2739
4480
6620
9045
11458
12027
11475
11
49
139
210
373
544
805
1034
1250
1459
1154
31
96
220
382
647
1072
1553
2284
3255
4611
5192
6636
7832
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and Wales in 1936-40 and 1952-54. For stomach the Japanese rates in 1952 are
4 or 5 times the English at ages under 45, and the ratio then falls to about 3 at 60.
After 70 Japan's rates decline. probably owing to incomplete ascertainment or
certification. For uterus the Japanese figure reaches a maximum about age 60 in
1938 and about age 65 in 1952, whereas the English rates continue to increase
with advancing age; and the ratio is about 3 to 1 at 35, falling by age 60 to 1.4
in 1938 and to 1.7 in 1952. For breast cancer death rates in both countries increase
throughout life, Japan's rates being a third to a quarter of the English rates in
early life and only one-ninth in late life. For all other cancer the ratio up to age
70 is about one-half.
Table III shows the trend ofthe percentage ratios as age advances from 25 to
70, and it is apparent that combined mortality from breast and uterine cancer in
TABLE III.-Death Rates of Women in Japan from Cancer of Breast, Uterus,
Stomach, Intestine and All Other Sites at Various Ages, expressed aspercentages
of the rates in England and Wales, 1938 and 1952*
25- 35- 40- 45- 50- 55- 60- 65-69
Breast-
1938 . . . 29 . 18 . 17 . 15 . 14 . 13 . 12 . 11
1952 . . . . 34 . 30 . 25 . 17 . 21 . 19 . 16 . 12
Uterus-
1938 . . . . 443 . 327 . 241 . 181 . 165 . 151 . 136 . 108
1952 . . . 230 . 300 . 315 . 307 . 245 . 191 . 173 . 165
Breast and uterus-
1938 . . . 206 . 154 116 . 85 . 77 . 68 . 60 . 48
1952 . . . . 116 . 117 . 107 . 99 . 96 . 81 72 . 63
Stomach-
1938 . . . . 278 . 320 . 290 . 243 . 239 . 253 . 208 . 157
1952 . . . . 450 . 518 . 457 . 345 . 325 . 318 . 293 . 257
Intestine and rectum-
1952 . . . . 47 . 44 . 45 . 36 . 36 . 39 . 35 . 37
All other sites*-
1952 . . . 58 . 60 . 59 . 51 51 . 54 . 51 . 52
* England and Wales rates used are for 1936-40 and 1952-54. "All other sites" exclude leu-
kaemia and Hodgkin's disease.
1938 was much higher in Japan than in England and Wales up to age 45, but at
ages thereafter the percentage ratio fell below 100, decreasing steadily to about
50 by age 65. In 1952 the percentage declined with advancing age from 117 at
ages before 40 to 63 at ages 65-69.
Table IV estimates the rates of dying from breast and uterine cancer during
the 15 years from 1937 to 1952 experienced by two "cohorts "ofwomen who were
aged 30-34 and 45-49 in 1937. In Japan each 100,000 in the younger group lost
59 by breast and 466 by uterine cancer, or 525 by the combined causes, whereas
in England and Wales the same number lost 309 by breast and 156 by uterine
cancer, or 465 by the combined causes. During the reproductive period Japan's
higher uterine mortality more than counteracted the low breast risk, and no
advantage began to accrue until after 45. In the next 15 years oflife each 100,000
Japanese women starting at ages 45-49 lost 135 by breast and 987 by uterine
cancer, or 1122 by the combined causes, whereas the same number of EnglishP. STOCKS
TABLE IV.-Estimated Proportions of Women Aged 30-34 and 45-49 in 1937 who
died during the next 15 years of Breast and Uterine Cancer in Japan and in
England and Wales
Aged 30-34 in 1937. Aged 45-59 in 1937.
Eng. Eng.
Japan. & Wales. Japan. & Wales.
Estimated population in 1937 (thousands) . 2,326 1,731 . 1,530 1,427
Estimated deaths in the cohort by 1952 from:
Breast cancer. . . . . . 1,383 5,352 2,083 13,141
Uterine cancer . . . . 10,853 2,693 15,096 8,804
Combined causes . . . . 12,236 8,045 . 17,179 21,945
Proportion per 100,000 alive in 1937 who
died in 15 years from
Breast cancer . . . . 59 309 . 135 921
Uterine cancer . . . 466 156 . 987 617
Combined causes . . . 525 465 . 1,122 1,537
women lost 921 by breast and 617 by uterine cancer, or 1538 in all. The total
expectation of dying of breast or uterine cancerduring thenext 30 years amongst
1000 women aged 30 must be about 20 in Japan and 22 in England and Wales,
the lower risk from breast cancer being almost compensated by the higher risk
from uterine cancer. Realisation of this must modify ideas about the effect
of prolonged lactation on the incidence of breast cancer particularly in view of
recent evidence that the important factor influencing the cervix cancer risk is
early marriage rather than number of parturitions (Wynder et al., 1954; Stocks,
1955).
Mortality at different agesfrom mnouth, oesophagus, intestine, larynx, andlungcancers,
and leukaemia
Table V compares the death rates in Japan in 1952 at various ages with the
corresponding mean annual rates in England and Wales in 1952-54 for parts
of the digestive tract, larynx and lung cancer, and leukaemia. Between ages
50 and 70 Japanese rates in men are about half the English rates for the buccal
cavity and pharynx, and are about double the English rates for the oesophagus.
For the intestine and rectum Japan's rates are about one-third ofthose in England
and Wales for men between ages 40 and 60, and the ratio then decreases, whilst
for women (as Table III shows) the ratio remains around 36 per cent from age
40 to 70 For the larynx the figures are similar in the two countries up to age 70,
but for lung cancer registered mortality of men in Japan is less than one-tenth
of the English rates at most ages, and amongst women the ratio is between one-
half and one-third. Leukaemia rates change little with age in Japan, and they
fail to show the increase from age 50 onwards which is such a pronounced feature
of the English statistics.
SUMMARY
Japanese mortality from malignant neoplasms as a whole ranks 9th for men
and 15th for women amongst the equivalent average death rates at ages 35-64
of 21 countries when arranged in descending order. The statistics for separate
forms of cancer up to age 70 may with safety be compared with those of other
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TABLE V.-Comparison between Age-specific Death Rates Per Million in Japan,
1952, and in England and Wales, 1952-54 from Cancer of Digestive and
Respiratory Organs and Leukaemia
Intestine and
rectum
(152-54).
Males.
E.
Japan. & W.
0 8
7
25
38
53
109
176
262
423
515
521
428
1 2
17
45
91
155
284
511
854
1514
2443
3825
4719
Intestine and
rectum
(152-54).
Females.
.
E.
Japan. & W.
0 5
8
20
47
63
104
184
252
377
386
426
305
0.9
17
45
105
174
288
469
719
1033
1570
2432
3667
Larynx
(161).
Males.
.
E.
Japan. & VW.
0.1
0 5
1 2
6
18
32
57
85
151
146
125
83
0.1
0.2
1 8
5
13
33
75
101
156
225
294
357
Larynx
(161).
Females.
£1
A
E.
Japan. & W.
0.1
1.1
0- 8
0- 8
8
11
15
28
32
34
42
33
0.1
0 8
2 2
3.3
7
13
17
19
24
32
33
39
Lung and
bronchus
(162-3).
Males.
E.
Japan. & W.
0 7
5
6
21
43
70
114
181
236
219
190
110
2 1
26
97
249
577
1259
2002
2543
2922
2592
2072
1267
Lung and
bronchus
(162-3).
Females.
E.
Japan. & W.
0 7
2.4
3.5
11
18
40
40
65
80
93
70
18
0-6
10
26
52
89
138
201
287
384
379
445
362
countries having good registration and diagnostic arrangements. At ages after
70 certification of cancer as cause of death is probably less complete than in many
countries of that class.
Comparison with England and Wales, and with Canada, shows that Japanese
rates in middle life are high for cancer of the stomach, oesophagus and uterus,
low for intestine, mouth and pharynx, breast and lung, and about the same for
larynx. Despite the very low mortality from breast cancer, the total risk of dying
from breast or uterine cancer between ages 30 and 60 is only slightly below that
in England and Wales. Leukaemia rates are almost constant throughout life in
Japan and do not show the increase after age 50 seen in English statistics.
It is suggested that a search for possible reasons for the low breast and high
uterine cancer mortality, and for the low intestinal and high gastro-oesophageal
cancer mortality in Japan might be helpful to the study of causation of these
forms of cancer.
Oesophagus
(150).
Males.
E.
Japan. & W.
0-1 0
1.2 1.2
5 5
15 11
45 20
95 53
208 99
362 170
550 277
602 451
587 699
415 848
Leukaemia
(204).
Females.
E.
Japan. & W.
Mouth and
pharynx
(140-8).
Males.
E.
Japan. & W.
0.2 2
2 2
4 7
9 11
12 19
22 47
40 92
72 148
78 170
100 491
131 799
97 1072
Leukaemia
(204).
Males.
E.
Japan. & W.
20 33
14 20
20 27
19 34
16 44
24 50
19 80
22 123
20 162
16 169
3 211
21 150
Age
group.
O-
25-
35-
40-
45-
50-
55-
60-
65-
70-
75-
80+
0-
25-
35-
40-
45-
50-
55-
60-
65-
70-
75-
80+
14
12
16
14
15
18
13
19
18
12
19
0
25
15
24
32
33
45
62
81
113
126
136
104
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